Cargando…
The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness?
The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040874/ https://www.ncbi.nlm.nih.gov/pubmed/30018839 |
| _version_ | 1783338903660396544 |
|---|---|
| author | Viale, Pamela Hallquist |
| author_facet | Viale, Pamela Hallquist |
| author_sort | Viale, Pamela Hallquist |
| collection | PubMed |
| description | The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs. |
| format | Online Article Text |
| id | pubmed-6040874 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Harborside Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60408742018-07-17 The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? Viale, Pamela Hallquist J Adv Pract Oncol Editorial The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs. Harborside Press 2017 2017-05-01 /pmc/articles/PMC6040874/ /pubmed/30018839 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
| spellingShingle | Editorial Viale, Pamela Hallquist The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title | The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title_full | The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title_fullStr | The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title_full_unstemmed | The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title_short | The Federal ’Right To Try’ Act: An Answer to New Treatments During Terminal Illness? |
| title_sort | federal ’right to try’ act: an answer to new treatments during terminal illness? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040874/ https://www.ncbi.nlm.nih.gov/pubmed/30018839 |
| work_keys_str_mv | AT vialepamelahallquist thefederalrighttotryactananswertonewtreatmentsduringterminalillness AT vialepamelahallquist federalrighttotryactananswertonewtreatmentsduringterminalillness |